Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 May 3;85(5):551-556.
doi: 10.1292/jvms.22-0571. Epub 2023 Mar 16.

Efficiency of immunocastration with an anti-gonadotropin-releasing hormone vaccine on cryptorchid bulls

Affiliations

Efficiency of immunocastration with an anti-gonadotropin-releasing hormone vaccine on cryptorchid bulls

Akira Goto et al. J Vet Med Sci. .

Abstract

Cryptorchid bulls have low economic value owing to the effects of masculinization. Moreover, surgical removal of an ectopic testis is difficult in certain clinical cases. Recently, immunocastration has garnered popularity as a nonsurgical castration method in pig farming; however, the effects of immunocastration on cryptorchid bulls are yet to be yet. Herein, we investigated endocrine changes due to immunocastration in cryptorchid bulls and studied its effectiveness. This study included 13 Holstein bulls diagnosed with cryptorchidism and classified into two groups based on pubertal period: <8 months of age (pregroup) and ≥8 months of age (postgroup). Antigonadotropin-releasing hormone (GnRH) vaccine was used for immunocastration, and two vaccine doses were administered. Blood testosterone and anti-Müllerian hormone (AMH) levels were measured and analyzed for endocrine evaluation. The testosterone levels significantly decreased following the start of immunocastration in both groups, thereby confirming the efficacy of antiGnRH vaccination in cryptorchid bulls. The AMH levels significantly increased in the pregroup with two antiGnRH vaccination, suggesting a compensatory response via the neutralization of GnRH antibodies. The AMH levels did not significantly change in the postgroup, indicating the partial suppression of AMH secretion in Sertoli cells during sexual maturation and failure of Sertoli cell maturation. Thus, we successfully restrained the serum testosterone levels in cryptorchid bulls using antiGnRH vaccine. The testosterone levels are a useful indicator of the immunocastration effect on cryptorchid bulls. Hereafter, a vaccine program that can sustain the castration effect on cryptorchid bulls is necessary.

Keywords: anti-Müllerian hormone; antiGnRH vaccine; bull; cryptorchid; immunocastration.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest associated with this manuscript.

Figures

Fig. 1.
Fig. 1.
Schedule outline of vaccination and blood sampling.
Fig. 2.
Fig. 2.
Distribution of serum testosterone levels and age in cryptorchid bulls at the start of the study. The dashed line indicates the standard pubertal period. Total cryptorchid bulls (n=13, mean age 9.0 ± 1.0 months). Blue dot: pre-group (n=6, <8 months of age; mean age, 6.0 ± 0.5 months). Orange dot: post-group (n=7, ≥8 months of age; mean age, 11.6 ± 1.1 months).
Fig. 3.
Fig. 3.
Changes in serum testosterone levels in both groups before and after immunocastration. The values are means ± SEM. a–b, c–d: Different letters indicate significant differences by the multiple comparison test within the group (P<0.05). Black arrows indicate vaccination. Blue line: pre-group (n=6, <8 months of age; mean age, 6.0 ± 0.5 months). Orange line: post-group (n=7, ≥8 months of age; mean age, 11.6 ± 1.1 months).
Fig. 4.
Fig. 4.
Changes in serum AMH levels in both groups before and after immunocastration. The values are means ± SEM. a–b: Different letters indicate significant differences by the multiple comparison test within the group (P<0.05). Black arrows indicate vaccination. Blue line: pre-group (n=6, <8 months of age; mean age, 6.0 ± 0.5 months). Orange line: post-group (n=7, ≥8 months of age; mean age, 11.6 ± 1.1 months).

Similar articles

Cited by

References

    1. Aksglaede L, Sørensen K, Boas M, Mouritsen A, Hagen CP, Jensen RB, Petersen JH, Linneberg A, Andersson AM, Main KM, Skakkebæk NE, Juul A. 2010. Changes in anti-Müllerian hormone (AMH) throughout the life span: a population-based study of 1027 healthy males from birth (cord blood) to the age of 69 years. J Clin Endocrinol Metab 95: 5357–5364. doi: 10.1210/jc.2010-1207 - DOI - PubMed
    1. Al-Attar L, Noël K, Dutertre M, Belville C, Forest MG, Burgoyne PS, Josso N, Rey R. 1997. Hormonal and cellular regulation of Sertoli cell anti-Müllerian hormone production in the postnatal mouse. J Clin Invest 100: 1335–1343. doi: 10.1172/JCI119653 - DOI - PMC - PubMed
    1. Almeida J, Conley AJ, Ball BA. 2013. Expression of anti-Müllerian hormone, CDKN1B, connexin 43, androgen receptor and steroidogenic enzymes in the equine cryptorchid testis. Equine Vet J 45: 538–545. doi: 10.1111/evj.12013 - DOI - PubMed
    1. Amann RP, Veeramachaneni DNR. 2007. Cryptorchidism in common eutherian mammals. Reproduction 133: 541–561. doi: 10.1530/REP-06-0272 - DOI - PubMed
    1. Barnes MA, Boockfor FR, Bierley ST, Kazmer GW, Halman RD, Dickey JF. 1981. Effect of unilateral castration and unilateral cryptorchidism on gonadotropin and testosterone response to gonadotropin releasing hormone in the bull. J Anim Sci 53: 1341–1350. doi: 10.2527/jas1981.5351341x - DOI - PubMed